|
Liu D, Wang M, Murthy V, McNamara DM, Nguyen TTL, Philips TJ, Vyas H, Gao H, Sahni J, Starling RC, Cooper LT, Skime MK, Batzler A, Jenkins GD, Barlera S, Pileggi S, Mestroni L, Merlo M, Sinagra G, Pinet F, Krej?í J, Chaloupka A, Miller JD, de Groote P, Tschumperlin DJ, Weinshilboum RM, Pereira NL |
| Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis
Circ Res 2023. 133 (10) : 810 - 825 |
Tognoni G, Franzosi MG, Garattini S |
Embedding patient- and public health-oriented research in a national health service: the GISSI experience
J R Soc Med 2019. 112(5) : 200 - 204 |
Pileggi S, De Chiara B, Magnoli M, Franzosi MG, Merlanti B, Bianchini F, Moreo A, Romeo G, Russo CF, Rizzo S, Basso C, Martinelli L, Maseri A; VAR Study Group. |
Sequencing of NOTCH1 gene in an Italian population with bicuspid aortic valve: Preliminary results from the GISSI OUTLIERS VAR study.
Gene 2019. 715 (143970) |
Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. |
Declining Risk of Sudden Death in Heart Failure.
N Engl J Med 2017. 377(1) : 41 - 51 |
Merlanti B, De Chiara B, Maggioni AP, Moreo A, Pileggi S, Romeo G, Russo CF, Rizzo S, Martinelli L, Maseri A; VAR Study Group. |
Rationale and design of GISSI OUTLIERS VAR Study in bicuspid aortic valve patients: prospective longitudinal, multicenter study to investigate correlation between surgical, echo distinctive features, histologic and genetic findings in phenotypically homogeneous outlier cases.
Int J Cardiol 2015. 199 : 180 - 185 |
Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA); GISSI-Heart Failure (GISSI-HF) Committees and Investigators. |
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Circulation 2015. 131 (17) : 1486 - 1494 |
Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G, GISSI-HF Investigators |
Predictors of Mortality in 6975 Patients with Chronic Heart Failure in the GISSI-HF Trial: Proposal for a Nomogram
Circ Heart Fail 2013. 6 : 31 - 39 |
Røysland R, Masson S, Omland T, Milani V, Bjerre M, Flyvbjerg A, Di Tano G, Misuraca G, Maggioni A P, Tognoni G, Tavazzi L, Latini R, GISSI-HF Investigators |
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial
Am Heart J 2010. 160 : 286 - 293 |
Røsjø H, Masson S, Latini R, Flyvbjerg A, Milani V, La Rovere T, Revera M, Mezzani A, Tognoni G, Tavazzi L, Omland T, GISSI-HF Investigators |
Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial
Eur J Heart Fail 2010. 12 : 519 - 556 |
Røsjø H, Masson S, Latini R, Flyvbjerg A, Milani V, La Rovere MT, Revera M, Mezzani A, Tognoni G, Tavazzi L, Omland T; GISSI-HF Investigators. |
Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial.
Eur J Heart Fail 2010. 12(6) : 549 - 556 |
GISSI-AF Investigators |
Valsartan for prevention of recurrent atrial fibrillation.
New Engl J Med 2009. 360(16) : 1606 - 1617 |
GISSI-HF Investigators |
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008. 372 : 1223 - 1230 |
GISSI-HF Investigators |
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008. 372 : 1231 - 1239 |
Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G, on behalf of GISSI-AF Investigators |
Rationale and design of the GISSI-atrial fibrillation trial: randomized, prospective, multicenter study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
J Cardiovasc Med 2006. 7 : 29 - 38 |
Macchia A, Levantesi G, Franzosi M G, Geraci E, Maggioni A P, Marfisi R M, Nicolosi G L, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R, GISSI-Prevenzione |
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Eur J Heart Fail 2005. 7(5) : 904 - 909 |
Temporelli PL, Giannuzzi P, Nicolosi GL, Latini R, Franzosi MG, Gentile F, Tavazzi L, Maggioni AP, for the GISSI-3 Echo Substudy Investigators |
Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodelling and survival alter acute myocardial infarction. Results of the GISSI-3 Echo Substudy
J Am Coll Cardiol 2004. 43 : 1646 - 1653 |
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL and Porcu M, on behalf of GISSI-HF Investigators |
Rationale and Design of the GISSI Heart Failure Trial: a Large Trial to Assess the Effects of n-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure
Eur J Heart Fail 2004. 6 : 635 - 641 |
Geraci E, Franzosi MG. |
Gli studi GISSI: genio e regolatezza
Janus 2003. 12 : 122 - 129 |
Franzosi MG, Tognoni G, Maggioni AP, Mauri F. |
Il GISSI ha cambiato il modo di fare ricerca in cardiologia. E non solo in Italia. Vent'anni dall'avvio del GISSI-1.
Cardiologia negli Ospedali 2003. 133 : 26 - 27 |
Villella M, Villella A, Santoro L, Santoro E, Franzosi MG, Maggioni AP, on behalf of GISSI Investigators |
Ergometric score systems after myocardial infarction: prognostic performance of Duke Treadmill Score, Veterans Administration Medical Centre Score and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction
Am Heart J 2003. 145 : 475 - 483 |
Barzi F, Woodward M, Marfisi RM, Tavazzi L, Valagussa F and Marchioli R on behalf of
GISSI-Prevenzione Investigators |
Mediterranean diet and all-causes mortality after
myocardial infarction: results from the GISSI-Prevenzione trial
Eur J Clin Nutr 2003. 57 : 604 - 611 |
Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G, on behalf of the GISSI-3 Investigators |
Risk and benefits of the early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: Analysis of the GISSI-3 database.
Am Heart J 2002. 144 : 1018 - 1025 |
Mauri F, Franzosi MG, Maggioni AP, Santoro E, Santoro L |
Clinical value of 12-lead electrocardiography to predict long-term prognosis in GISSI-1 patients
J Am Coll Cardiol 2002. 39 : 1594 - 1600 |
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi G, Tognoni G, Tucci C, Valagussa F, on behalf of GISSI-Prevenzione investigators |
Early protection against sudden coronary death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
Circulation 2002. 105 : 1897 - 1903 |
de Kam PJ, Nicolosi GL, Voors AA, van den Berg P, Brouwer J, van Deldhuises DJ, Barlera S, Maggioni AP, Giannuzzi P, Temporelli PL, Latini R, van Gilst WH |
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSi-3 data
Eur Heart J 2002. 23 : 536 - 542 |
Nollo G, Del Greco M, Disertori M, Santoro E, Maggioni AP, Sanna GP. |
Absence of slowest oscillations in short term heart rate variability of post-myocardial infarction patients. GISSI-3 arrhythmias substudy.
Autonomic Neuroscience: Basic and Clinical 2001. 90 : 127 - 131 |
Volpi A, Cavalli A, Turato R, Barlera S, Santoro E, Negri E, on behalf of the GISSI-3 Investigators |
Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base
Am Heart J 2001. 142 : 87 - 92 |
Franzosi MG, Brunetti M, Marchioli R, Marfisi MR, Tognoni G, Valagussa F, on behalf of GISSI-Prevenzione Investigators |
Cost-effectiveness analysis of n-3 polyunsatured fatty acids (PUFA) after myocardial infarction. Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial
Pharmacoeconomics 2001. 19 : 411 - 420 |
Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G, on behalf of the GISSI-3 Investigators |
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
Heart 2001. 86 : 527 - 532 |
Maggioni AP, Tognoni G, on behalf of GISSI Investigators |
Risk stratification in the thrombolytic era: data from the GISSI experience
2001. 90 - 102 |
Marchioli R, Tognoni G, Barringer TD, Bhatnagar D, Berry EM, Burr M, De Caterina R, Harris W, Kromhout D, Lands W, Leaf A, Maggioni AP, Nordøy A, Simopoulos A, von Shacky C, Singh RB, Siscovich D, Tavazzi L, Valagussa F |
Executive summary
Eur Heart J Suppl 2001. 3 : D1-D3 |
Maggioni AP, Tavazzi L, Marchioli R, Tognoni G, Avanzini F, Roncaglioni MC, on behalf of the GISSI-group |
Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure
Eur Heart J Suppl 2001. 3(Suppl D) : D106 - D109 |
Latini R, Tognoni G, Maggioni AP, Baigent C, Braunwald E, Chen ZM, Collins R, Flather M, Franzosi MG, Kjekshus J, Køber L, Liu L, Peto R, Pfeffer M, Pizzetti F, Santoro E, Sleight P, Swedberg K, Tavazzi L, Wang W, Yusuf S, on behalf of the Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group |
Clinical effects of early Angiotensin-Converting Enzyme Inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin. Systematic overview of individual data from 96,712 randomized patients
J Am Coll Cardiol 2000. 35 : 1801 - 1807 |
Santoro E, Nicolis E, Franzosi MG |
Telecommunication technology for the management of large scale clinical trials: the GISSI experience
Comput Methods Programs Biomed 1999. 60 : 215 - 223 |
Santoro E, Nicolis E, Franzosi MG, Tognoni G |
Internet for clinical trials: past, present, and future
Controlled Clin Trials 1999. 20 : 194 - 201 |
GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico) |
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
Lancet 1999. 354 (9177) : 447 - 455 |
Maggioni AP, Latini R |
How to use ACE ihibitors, b-blockers, and newer terapies in AMI
Am Heart J 1999. 138 : S183-S187 |
Malacrida R, Genoni M, Maggioni AP, Spataro V, Parish S, Palmer A, Collins R, Moccetti T, for the Third International Study of Infarct Survival Collaborative Group |
A comparison of the early outcome of acute myocardial infarction in women and men
New Engl J Med 1998. 338 : 8 - 14 |
Franzosi MG, Maggioni AP, Santoro E, Tognoni G, Cavalieri E |
Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Results from GISSI-3 Trial
Pharmacoeconomics 1998. 13 : 337 - 346 |
Franzosi MG, Santoro E, De Vita C, Geraci E, Lotto A, Maggioni AP, Mauri F, Rovelli F, Santoro L, Tavazzi L, Tognoni G, on behalf of GISSI Investigators |
Ten-year-follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Results of Gruppo per lo Studio della Sopravvivenza nell'Infarto-1 Study
Circulation 1998. 98 : 2659 - 2665 |
Chiarella F, Santoro E, Domenicucci S, Maggioni AP, Vecchio C, on behalf of the GISSI-3 Investigators |
Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 Study
Am J Cardiol 1998. 81 : 822 - 827 |
Bobbio M, Bergerone S, Maggioni AP, Malacrida R, Franzosi MG, Barlera S, Tognoni G, on the behalf of the GISSI-3 Investigators |
Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction: The GISSI-3 database
Am Heart J 1998. 135 : 443 - 448 |
Maggioni AP, Geraci E |
Very early administration of ACE-inhibitors in acute myocardial infarction
Int J Cardiol 1998. 65 (Suppl.1) : S61-S64 |
Zuanetti G, Latini R, Maggioni AP, Franzosi MG, Santoro L, Tognoni G, for the GISSI-3 Investigators |
Effect of the ACE-inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction. Data from the GISSI-3 study
Circulation 1997. 96 : 4239 - 4245 |
Huckell V, Bernstein V, Cairns JA, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A |
Angiotensin-converting enzyme inhibition in myocardial infarction. Preface, Part I: Clinical Data, Parte 2: Clinical issues and contoversies
Can J Cardiol 1997. 13 : 160 - 182 |
Moccetti T, Malacrida R, Pasotti E, Sessa F, Genoni M, Barlera S, Turazza F, Maggioni AP, for the Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) |
Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database
Arch Intern Med 1997. 157 : 865 - 869 |
Carinci F, Nicolucci A, Ciampi A, Labbrozzi D, Bettinardi O, Zotti AM, Tognoni G, on behalf of the Gruppo Italiano per lo Studio della Sopravvivenza all'Infarto Miocardico |
Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction. Application of recursive partitioning techniques to the GISSI-2 Data-base
Eur Heart J 1997. 18 : 835 - 845 |
Tavazzi L, Volpi A, for the GISSI Investigators |
Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Trial
Circulation 1997. 95 : 1341 - 1345 |
Tognoni G, Latini R, Maggioni AP |
ACE inhibitors in myocardial infarction (Reply to the Editor)
Circulation 1996. 94 : 2315 |
The GISSI-3 APPI Study Group |
Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction (The GISSI-3 APPI [Angina-Precoce Post-Infarto] study)
Am J Cardiol 1996. 78 : 1191 - 1197 |
Del Greco M, Nollo G, Disertori M, Sanna GP, Maggioni AP, Santoro E, Tarantino F, Della Mea MT, Antolini R, Micciolo R, on behalf of GISSI-3 Sottoprogetto Aritmie Investigators |
GISSI-3 arrhythmias subproject: a multicenter study on the role of filtering techniques on the time-domain analysis of signal-averaged electrocardiogram after myocardial infarction
New Trends in Arrhythmias 1996. XI : 660 - 665 |
Fresco C, Avanzini F, Bosi S, Franzosi MG, Maggioni AP, Santoro L, Bellanti G, on behalf of GISSI-2 Investigators |
Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis
J Hypertension 1996. 14 : 743 - 750 |
Marchioli R, Bomba E, Tognoni G |
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease
Lancet 1996. 347 : 467 - 468 |
Latini R, Maggioni AP, Zuanetti G, on behalf of GISSI-3 Investigators |
Myocardial infarction: when and how should we initiate treatment with ACE inhibitors?
Cardiology 1996. 87 (Suppl 1) : 16 - 22 |
Zuanetti G, Neilson JMN, Latini R, Santoro E, Maggioni AP, Ewing DJ, on behalf of GISSI-2 Investigators |
Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results
Circulation 1996. 94 : 432 - 436 |
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico, (Writing Commitee: Nicolosi GL, Latini R, Marino P, Maggioni AP, Barlera S, Franzosi MG, Geraci E, Santoro L, Tavazzi L, Tognoni G, Vecchio C, Volpi A |
The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial
Eur Heart J 1996. 17 : 1646 - 1656 |
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico |
Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: The GISSI-3 trial
J Am Coll Cardiol 1996. 27 : 337 - 344 |
Marchioli R, Marfisi RM, Carinci F, Tognoni G |
Meta-analysis, clinical trials, and trasferability of research results into practice. The case of cholesterol-lowering interventions in the secondary Prevention of coronary heart disease
Arch Intern Med 1996. 156 : 1158 - 1172 |
Villella A, Maggioni AP, Villella M, Giordano A, Turazza FM, Santoro E, Franzosi MG, on behalf of the GISSI-2 Investigators |
Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base
Lancet 1995. 346 : 523 - 529 |
Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G, for the meeting participants |
ACE inhibitor use in patients with myocardial infarction
Circulation 1995. 92 : 3132 - 3137 |
Gruppo Italiano per lo Studio della Sopravvivenza dell'Infarto (GISSI)-Nursing |
GISSI-Nursing: valutazione della percezione della qualità della salute da parte del paziente con infarto miocardico. Rapporto finale dello studio
Riv Inf 1995. 14 : 16 - 29 |
Franzosi MG, Latini R, Maggioni AP, Zuanetti G, Tognoni G |
Megatrials in myocardial infarction (letter to the Editor)
Lancet 1995. 346 : 1369 |
Avanzini F, Latini R, Maggioni AP, Colombo F, Santoro E, Franzosi MG, Tognoni G, on behalf of the GISSI Investigators |
Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)
Arch Intern Med 1995. 155 : 1041 - 1045 |
GISSI-Avoidable Delay Study Group |
Epidemiology of avoidable delay in the care of acute myocardial infarction patients in Italy. A GISSI-generated study
Arch Intern Med 1995. 155 : 1481 - 1488 |
Levantesi G, Volpi A, Di Marco G, Bertoli D, Tusa M, Cavalli A, Rosselli P, Dalle Mule J, Gibelli G, Pirazzini L, Aletto C, Pizzetti F, Bechi S, Stuto A, Barlera S, Maggioni AP, a nome dei Ricercatori del GISSI-2 |
La funzione ventricolare sinistra nell'infarto del miocardio. Analisi delle variabili prognostiche nel data-base dello studio GISSI-2
G Ital Cardiol 1995. 25 : 1177 - 1186 |
Tognoni G, on behalf of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico |
ACE inhibitors after myocardial infarction (letter to the Editor)
Lancet 1994. 343 : 1633 - 1634 |
Mauri F, Maggioni AP, Franzosi MG, De Vita C, Santoro E, Santoro L, Giannuzzi P, Tognoni G, for the GISSI-2 Investigators |
A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent
J Am Coll Cardiol 1994. 24 : 600 - 607 |
Tognoni G |
Role of angiotensin-converting enzyme inhibitors in myocardial infarction
Lancet 1994. 344 : 758 - 759 |
Fibrinolytic Therapy Trialist's (FTT) Collaborative Group |
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
Lancet 1994. 343 : 311 - 322 |
Marino P, Nidasio G, Golia G, Franzosi MG, Maggioni AP, Santoro E, Santoro L, Zardini P, on behalf of the GISSI-2 Investigators |
Frequency of predischarge ventricular arrhythmias in postmyocardial infarction patients depends on residrual left ventricular pump performance and is independent of the occurence of acute reperfusion
J Am Coll Cardiol 1994. 23 : 290 - 295 |
Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G, (ad hoc Working Group of GISSI-2 data-base) |
Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis
J Am Coll Cardiol 1994. 24 : 608 - 615 |
Gruppo Italiano per lo Studio della Sopravvivenza dell'Infarto Miocardico (GISSI) |
GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
Lancet 1994. 343 : 1115 - 1122 |
GISSI-3 Steering Committee |
From GISSI-1 to GUSTO: ten years of clinical trials on thrombolysis
Eur Heart J 1994. 15 : 1155 - 1157 |
Gnecchi-Ruscone T, Piccaluga E, Guzzetti S, Contini M, Montano N, Nicolis E, on behalf of GISSI-2 Investigators |
Morning and monday: critical periods for the onset of acute myocardial infarction. The GISSI-2 study experience
Eur Heart J 1994. 15 : 882 - 887 |
Nobili A, D'Avanzo B, Santoro L, Ventura G, Todesco P, La Vecchia C, on behalf of GISSI-EFRIM Investigators |
Serum cholesterol and acute myocardial infarction: a case-control study from the GISSI-2 trial
Br Heart J 1994. 71 : 468 - 473 |
Negri E, La Vecchia C, Nobili A, D'Avanzo B, Bechi S, on behalf of GISSI-EFRIM Investigators |
Cigarette smoking and acute myocardial infarction
Eur J Epidemiol 1994. 10 : 361 - 366 |
Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G, (the ad hoc Working Groups of GISSI-2 Data Base) |
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base
Circulation 1993. 88 : 416 - 429 |
Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili A, Tognoni G, on behalf of GISSI-EFRIM Investigators |
Tar yield of cigarettes and risk of acute myocardial infarction
Br Med J 1993. 306 : 1567 - 1570 |
Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, de Jaegere P, van Domburg R, Boersman E, Franzosi MG, Califf R, Schröder R, Braunwald E |
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
Lancet 1993. 342 : 1523 - 1528 |
Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G, on behalf of GISSI-2 Investigators |
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results
Circulation 1993. 87 : 312 - 322 |
Santoro E, Franzosi MG, Nicolis E |
A computerized network system for the management of a large scale multicentre clinical trial: the GISSI-3 trial.
Controlled Clin Trials 1993. 14 : 430 |
Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG, on behalf of GISSI-2 Investigators |
Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study
J Am Coll Cardiol 1993. 22 : 1788 - 1794 |
Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G, on behalf of the Investigators of the GISSI-2 |
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis
New Engl J Med 1993. 329 : 1442 - 1448 |
|
Protocollo dello studio GISSI-Prevenzione. Studio di intervento preventivo sulle componenti aterosclerotica e trombotica del rischio post-infarto
G Ital Cardiol 1993. 23 : 1053 - 1061 |
Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G, the GISSI-2 and the International Study Group |
The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment
New Engl J Med 1992. 327 : 1 - 6 |
Roncaglioni MC, Santoro L, D'Avanzo B, Negri E, Nobili A, Ledda A, Pietropaolo F, Franzosi MG, La Vecchia C, Feruglio GA, Maseri A, on behalf of GISSI-EFRIM Investigators |
Role of family history in patients with myocardial infarction. An Italian case-control study
Circulation 1992. 85 : 2065 - 2072 |
GISSI-2 and International Study Group |
Six-month survival in 20891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin
Eur Heart J 1992. 13 : 1692 - 1697 |
GISSI-3 Gruppo Italiano per lo Studio della Sopravvivenza dell'Infarto Miocardico |
GISSI-3: Study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction
Am J Cardiol 1992. 70 : 62C - 69C |
Negri E, Santoro L, D'Avanzo B, Nobili A, La Vecchia C, on behalf of GISSI-EFRIM Investigators |
Body mass and acute myocardial infarction
Prev Med 1992. 21 : 292 - 301 |
Staszewsky L, Maggioni AP, Franzosi MG, Tognoni G |
Infarto agudo de miocardio: elección o inducción del tratamiento?
Cardiologia Intercontinental 1992. 1 : 3 - 9 |
Maggioni AP, Franzosi MG, Farina ML, Santoro E, Celani MG, Ricci S, Tognoni G, on behalf of the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) |
Cerebrovascular events after myocardial infarction: analysis of the GISSI trial
Br Med J 1991. 302 : 1428 - 1431 |
Associazione Nazionale Medici Cardiologi Ospedalieri-ANMCO, Istituto di Ricerche Farmacologiche 'Mario Negri' |
Protocollo di ricerca GISSI-3
G Ital Cardiol 1991. 21 : 779 - 788 |
The International Study Group |
In-hospital mortality and clinical course of 20891 patients with suspected acute myocardial infarction randomised between alteplase or streptokinase with or without heparin
Lancet 1990. 336 : 71 - 75 |
Gruppo Italiano per lo Studio della Sopravvivenza dell'Infarto Miocardico |
GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction
Lancet 1990. 336 : 65 - 71 |
Marino P, Zanolla L, Zardini P, on behalf of the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) |
Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial
J Am Coll Cardiol 1989. 14 : 1149 - 1158 |
Tognoni G, D'Avanzo B, Franzosi MG, Gramenzi AG, La Vecchia C, Maggioni AP, Mezzanotte G, Nobili A, Pogna M, Volpi A, Feruglio GA, Fresco C, Maseri A, Andreotti F, Shoulders C, Sperti G |
GISSI-2. Sottoprogetto aspetti epidemiologici e genetici dei fattori di rischio per infarto miocardico
G Ital Cardiol 1988. 18 : 770 - 772 |
Franzosi MG, Mauri F, Pampallona S, Bossi M, Matta F, Farina ML, Tognoni G, on behalf of the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) |
The GISSI Study: further analysis
Circulation 1987. 76 (Suppl II) : II-52-II-56 |
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) |
Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study
Lancet 1987. ii : 871 - 874 |
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) |
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
Lancet 1986. i : 397 - 402 |
